Scholars Central

Conference abstractPublished 12 Aug 2013

Toward safe and effective gene and cell therapies using human artificial chromosomes and stem cells

Authors: Narumi Uno, Kana Ueda, Yuichi Iida, Yuna Yakura, Hajime Kurosaki, Katsuhiro Uno, Mitsuhiko Osaki, Tetsuya Ohbayashi, Yasuhiro Kazuki, Masaharu Hiratuka, Mitsuo Oshimura

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Random integration of conventional gene delivery vectors can be associated with transgene-silencing. Furthermore, integrated sequences can activate oncogenes adjacent to the insertion site, resulting in the activation or silencing of transgenes. Human artificial chromosome (HAC) is exogenous mini-chromosome artificially created by chromosome engineering. Various HACs exhibit several potential characteristics desired for an ideal gene delivery vector, including stable episomal maintenance and the capacity to carry large genomic loci with their regulatory elements, thus allowing the physiological regulation of the introduced gene in a manner similar to that of native chromosomes. For ideal gene and cell - therapy using iPS cells, following are crucial: efficient generation and differentiation of iPS cells; no integration of transgene into the host genome. Most importantly, it is necessary to evade a problem of teratoma formation and malignant transformation when using the iPS cells to cell transplantation therapy. Currently, we have constructed HAC-based cell-reprogramming vectors. Then, mouse and human iPS cells were generated using the HAC vectors. These iPS cells have no integration of transgene, and showed normal karyotype. To show their pluripotency, these iPS cells differentiated to three germ layer cells by generation of teratoma. We also aim to develop a safeguard system to eliminate undifferentiated cells and malignant transformation of transplanted cells using HAC.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Advancements in Genetic Engineering.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalAdvancements in Genetic Engineering
  • SubjectGenetics & Molecular Biology
  • SubjectEngineering
  • BylineArticles whose byline prints “Narumi Uno”
  • BylineArticles whose byline prints “Kana Ueda”
  • BylineArticles whose byline prints “Yuichi Iida”
  • BylineArticles whose byline prints “Yuna Yakura”
  • BylineArticles whose byline prints “Hajime Kurosaki”
  • BylineArticles whose byline prints “Katsuhiro Uno”
  • BylineArticles whose byline prints “Mitsuhiko Osaki”
  • BylineArticles whose byline prints “Tetsuya Ohbayashi”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels